CCS
TNDM icon

Crosspoint Capital Strategies’s Tandem Diabetes Care TNDM Stock Holding History

Crosspoint Capital Strategies’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.23M Buy
+35,196
New +$1.85M 4.04% 1
2018
Q4 		– Sell
-126,282
Closed -$5.41M – 53
2018
Q3 		$5.41M Sell
126,282
-2,818
-2% -$98.4K 8.85% 1
2018
Q2 		$2.84M Buy
+129,100
New +$1.59M 5.44% 1

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Crosspoint Capital Strategies's TNDM Position: Q1 2019 in Review

Crosspoint Capital Strategies opened a new position in Tandem Diabetes Care (TNDM) in Q1 2019: 35,196 shares worth $2.23M. The stake represents 4.04% of the portfolio and ranks #1 among its holdings. This is a return to the name: Crosspoint Capital Strategies previously reported a position in TNDM as recently as Q3 2018.

Crosspoint Capital Strategies first reported a position in TNDM in Q2 2018 and has held it in 3 quarters since. The position peaked at $5.41M in Q3 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Crosspoint Capital Strategies held 35,196 shares of Tandem Diabetes Care worth $2.23M as of Q1 2019.
  • Tandem Diabetes Care was a new Crosspoint Capital Strategies position in Q1 2019.
  • Tandem Diabetes Care made up 4.04% of Crosspoint Capital Strategies's portfolio in Q1 2019, its #1 holding.
  • Crosspoint Capital Strategies first reported a position in Tandem Diabetes Care in Q2 2018 and has held it in 3 quarters since.
  • Crosspoint Capital Strategies's Tandem Diabetes Care position peaked at $5.41M in Q3 2018.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2019, filed 13 May 2019.